首页> 外文期刊>Yonsei Medical Journal >Intestinal Beh?et's Disease: A True Inflammatory Bowel Disease or Merely an Intestinal Complication of Systemic Vasculitis?
【24h】

Intestinal Beh?et's Disease: A True Inflammatory Bowel Disease or Merely an Intestinal Complication of Systemic Vasculitis?

机译:肠道BEP?等疾病:真正的炎症肠疾病或仅仅是全身血管炎的肠道并发症?

获取原文
           

摘要

Beh?et's disease (BD) is a multi-systemic inflammatory disorder of an unknown etiology and shows a chronic recurrent clinical course. When the disease involves the alimentary tract, it is called intestinal BD because of its clinical importance. Intestinal BD is more frequently reported in East Asian countries than in Western or Middle Eastern countries. While any part of the gastrointestinal tract can be involved, the most common location of intestinal BD is the ileocecal area. A few, large, deep ulcerations with discrete border are characteristic endoscopic findings of intestinal BD. Currently, there is no single gold standard test or pathognomonic finding of intestinal BD. However, recently developed novel diagnostic criteria and a disease activity index have helped in assessing intestinal BD. As intestinal BD shares a lot of characteristics with inflammatory bowel disease, including genetic background, clinical manifestations, and therapeutic strategies, distinguishing between the two diseases in clinical practice is quite difficult. However, biologic agents such as anti-tumor necrosis factor α antibody shows a considerable efficacy similar to inflammatory bowel disease cases. It is important to distinguish and treat those two disease entities separately from the standpoint of precise medicine. Clinicians should require comprehensive knowledge regarding the similarities and differences between intestinal BD and inflammatory bowel disease for making an accurate clinical decision.
机译:ET的疾病(BD)是一种未知病因的多全身炎症障碍,并显示慢性复发性临床疗程。当疾病涉及消化道时,由于其临床重要性,它被称为肠BD。在东亚国家比西部或中东国家更常见的肠BD更常见。虽然可以涉及任何部分胃肠道,但肠道BD的最常见位置是回肠区域。具有离散边框的少数大,深的溃疡是肠道BD的特征内窥镜发现。目前,没有单一的金标准测试或肠道BD的病例发现。然而,最近开发的新型诊断标准和疾病活动指标有助于评估肠道BD。由于肠道BD与炎症性肠病共享了大量特征,包括遗传背景,临床表现和治疗策略,区分临床实践中的两种疾病是非常困难的。然而,生物学剂如抗肿瘤坏死因子α抗体显示出与炎症性肠病病例类似的相当大的疗效。与精确药物的角度分开区分和治疗这两种疾病实体。临床医生应要求肠道BD与炎症性肠病之间的相似性和差异进行全面了解,以进行准确的临床决策。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号